$25M sweet spot round size
Most of their 175 investments are in rounds between $28M and $84M
1996
Olema Oncology raised $130M on September 5, 2023
Investors: Logos Global Management, LP, Lightspeed Venture Partners, Woodline Partners LP and Vivo Capital
瑞龙诺赋(上海)医疗科技有限公司 raised $27M on August 30, 2023
Investors: GGV Capital, Lilly Asia Ventures, 经纬创投(北京)投资管理顾问有限公司 and Vivo Capital
COMPASS Pathways raised $125M on August 16, 2023
Investors: Soleus Capital Management, L.P., Laurion Capital Management LP, Partner Fund Management, RA Capital Management, L.P., Surveyor Capital, Logos Global Management, LP, TCG X, Armistice Capital LLC and Vivo Capital
Icosavax, Inc. raised $68M on May 22, 2023
Investors: Logos Global Management, LP, TCG X and Vivo Capital
Delcath Systems, Inc raised $85M on March 27, 2023
Investors: Logos Global Management, LP and Vivo Capital
EpiBiologics raised $50M on March 22, 2023
Investors: Polaris Partners, GV and Vivo Capital
Unicycive Therapeutics raised $30M on March 6, 2023
Investors: Logos Global Management, LP, RA Capital Management, L.P. and Vivo Capital
瑞龙诺赋(上海)医疗科技有限公司 raised undisclosed on December 21, 2022
Investors: 经纬创投(北京)投资管理顾问有限公司, Lilly Asia Ventures, GGV Capital and Vivo Capital
PULMOCIDE LIMITED raised $52M on December 6, 2022
Investors: 旭化成ファーマ(株), JEITO, F-Prime Capital Partners, S.R. One Ltd, Longwood Fund, IP Group plc, SV Life Sciences and Vivo Capital
Rgenta Therapeutics Inc. raised $52M on November 29, 2022
Investors: 经纬创投(北京)投资管理顾问有限公司, Delos Capital, Lilly Asia Ventures, 凯泰资本, 中金公司, Lengend Star and Vivo Capital